Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections

1. Arca-Suárez, J.
2. Lasarte-Monterrubio, C.
3. Rodiño-Janeiro, B.-K.
4. Cabot, G.
5. Vázquez-Ucha, J.C.
6. Rodríguez-Iglesias, M.
7. Galán-Sánchez, F.
8. Beceiro, A.
9. González-Bello, C.
10. Oliver, A.
11. Bou, G.